Recommended
product-img
  • Products
  • Discover MP Targets
  • Discover Research Areas
  • mProX™ Human PAK4 Stable Cell Line

    [CAT#: S01YF-1023-PY43]
    Product Category:
    Membrane Protein Stable Cell Lines
    Subcategory:
    Kinase Cell Lines

    Datasheet MSDS Request COA

    Certificate of Analysis Lookup
    To download a Certificate of Analysis, please enter a lot number in the search box below. Note: Certificate of Analysis not available for kit components.
    Lot Number

    Made to Order Inquiry

    Inquiry
    Host Cell Type:
    Membrane Protein Engineering:
    Fluorescent Marker:
    Resistance:
    Deliverable:

    Based on this stable cell line, we also provide cell-based in vitro assays to evaluate the effects of your compounds or antibodies.

    Sub Cat Product Name Target Protein Species Host Cell Type Assay Types Inquiry Datasheet
    S01YF-1222-KX418 Magic™ Human PAK4 in Vitro Assay Human Kinase Assay

    Product Information

    Target Family
    Kinases/Enzyme
    Target Protein Species
    Human
    Host Cell Type
    HEK293;CHO-K1;HeLa
    Target Classification
    Kinase Cell Lines
    Target Research Area
    Cancer Research
    Related Diseases
    Endometrial Cancer
    Gene ID
    Human:10298
    UniProt ID
    Human:O96013

    Product Properties

    Biosafety Level
    Level 1
    Activity
    Yes
    Quantity
    10⁶ cells per vial
    Applications
    PAK4 inhibitors have shown promise in various applications related to cancer treatment. In one study, 4-(3-1H-indazolyl)amino quinazoline derivatives were synthesized as PAK4 inhibitors and exhibited potent inhibitory activity against PAK4. The compound 27e showed the strongest antiproliferative activity against A549 cells and induced apoptosis and cell cycle arrest. Additionally, PAK4 inhibition has been shown to potentiate the activity of Gemcitabine in pancreatic ductal adenocarcinoma (PDAC) cells by inhibiting key signaling pathways. Furthermore, PAK4 silencing, in combination with immunogenic phototherapy in engineered extracellular vesicles (EVs), has demonstrated synergistic antitumor effects. Lastly, the combination of PAK4 inhibitors with KRASG12C inhibitors has enhanced antitumor activity and survival in preclinical models of KRASG12C mutant pancreatic and lung cancers. Overall, PAK4 inhibitors show promise as potential targets for the development of novel anticancer therapies.

    Protocols

    Please visit our protocols page.

    Customer Reviews

    There are currently no Customer reviews or questions for mProX™ Human PAK4 Stable Cell Line (S01YF-1023-PY43). Click the button above to contact us or submit your feedback about this product.

    FAQ

    chat Alex Jones (Verified Customer)

    How does PAK4 influence colorectal cancer progression? Sep 30 2022

    chat Patrick Liam (Creative Biolabs Scientific Support)

    PAK4 promotes colorectal cancer progression by phosphorylating and activating the β-catenin/MEK-ERK signaling pathway. Sep 30 2022

    chat Taylor Brown (Verified Customer)

    Can PAK4 inhibitors alleviate hepatic ischemia-reperfusion injury? Apr 07 2021

    chat Patrick Liam (Creative Biolabs Scientific Support)

    Yes, PAK4 inhibitors like SPA7012 have shown effectiveness in alleviating ischemia-reperfusion-induced liver damage by stabilizing Nrf2. Apr 07 2021
    Please note: All products are "FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR CLINICAL PROCEDURES" For licensing inquiries, please contact
    Send Inquiry Send Inquiry
    Inquiry Basket
    compare

    Go to compare